EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Realizing the promise of ‘La Dolce Vita’ via chemical biology: glycan‐motif editing of sLe X for precision cancer therapeutics

Barbara Richichi iD, Robert Sackstein

The FEBS Journal · 2025

DOI: 10.1111/febs.70079 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2025. Verfasst von Barbara Richichi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry 'Ugo Schiff', University of Firenze, Italy. Hauptthemen laut MEDLINE: Neoplasms, Polysaccharides, Precision Medicine, Oligosaccharides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, H2020 Marie Skłodowska-Curie Actions, United States National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The convergence of glycochemistry and glycobiology is enabling the creation of new therapeutic approaches with unprecedented capacity to alter cell and organismic biology using strategies that can uniquely and specifically custom‐modify the expression of key cell surface glycan motifs. We define this evolving field of chemical biology as ‘glycan‐motif editing’, and one of the principal targets of this glycoengineering effort is the sialofucosylated terminal lactosaminyl glycan known as sLe X (CD15s). This tetrasaccharide structure plays pivotal roles in both steady‐state and malignant hematopoiesis, in regulation of the immune response, and in cancer metastasis. Within this biological framework, we discuss the immense potential of glycan‐motif editing in enabling precision therapeutics that will profoundly improve outcomes for patients suffering from a wide variety of disabling and life‐threatening conditions, particularly cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPolysaccharidesPrecision MedicineOligosaccharidesHumansAnimals

Stichwörter der Autor:innen

E‐selectinE‐selectin ligandfucosyltransferasefucosyltransferase inhibitorglycan‐motif editingglycocalyxglycocalyx editingglycomimeticssLeXtranslational glycobiology

Substanzen

PolysaccharidesOligosaccharides

Autor:innen und Institutionen

  • Department of Chemistry 'Ugo Schiff', University of Firenze, Italy.
  • Department of Translational Medicine, and Translational Glycobiology Institute, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.

ORCID-Profile: Barbara Richichi

Förderung

  • NCI NIH HHS
  • H2020 Marie Skłodowska-Curie Actions
  • United States National Institutes of Health/National Cancer Institute

Zitieren

APA

Richichi, B., & Sackstein, R. (2025). Realizing the promise of ‘La Dolce Vita’ via chemical biology: glycan‐motif editing of sLe X for precision cancer therapeutics. The FEBS Journal. https://doi.org/10.1111/febs.70079

Vancouver

Richichi B, Sackstein R. Realizing the promise of ‘La Dolce Vita’ via chemical biology: glycan‐motif editing of sLe X for precision cancer therapeutics. The FEBS Journal. 2025. doi:10.1111/febs.70079

BibTeX
@article{Richichi2025,
  author = {Richichi, Barbara and Sackstein, Robert},
  title = {Realizing the promise of ‘La Dolce Vita’ via chemical biology: glycan‐motif editing of sLe X for precision cancer therapeutics},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70079}
}
Kostenlos starten →